You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Claims for Patent: 8,309,126


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,309,126
Title:Dispersible bosentan tablet
Abstract: The invention relates to dispersible tablets comprising the compound 4-tert-butyl-N-[6-(2-hydroxy-ethoxy)-5-(2-methoxy-phenoxy)-2-(pyrimidin-2- -yl)-pyrimidin-4-yl]-benzenesulfonamide.
Inventor(s): Holman; Lovelace (Arlesheim, CH), Trenktrog; Timm (Binningen, DE)
Assignee: Actelion Pharmaceuticals, Ltd. (Allschwill, CH)
Application Number:13/154,588
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,309,126
Patent Claims: 1. A dispersible tablet composition comprising an active ingredient consisting of compound I of the formula ##STR00002## or a pharmaceutically acceptable salt or solvate thereof, and pharmaceutically acceptable excipients.

2. The dispersible tablet according to claim 1 comprising the following pharmaceutically acceptable excipients: a) at least one filler and b) at least one lubricant.

3. The dispersible tablet according to claim 2 further comprising at least one disintegrant.

4. The dispersible tablet according to any one of the preceding claims comprising at least one acidifying agent and/or at least one flavouring agent and/or at least one sweetening agent.

5. The dispersible tablet according to claim 1 comprising the following pharmaceutically acceptable excipients: one or more fillers in a total amount of 40 to 85% in weight based on the total weight of the dispersible tablet, one or more disintegrants in a total amount of 0.5 to 20% in weight based on the total weight of the dispersible tablet, one or more glidants in a total amount of 0.1 to 5% in weight based on the total weight of the dispersible tablet, one or more acidifying agents in a total amount of 0.5 to 13% in weight based on the total weight of the dispersible tablet, one or more flavouring agents in a total amount of 1 to 15% in weight based on the total weight of the dispersible tablet, one or more sweetening agents in a total amount of 0.1 to 10% in weight based on the total weight of the dispersible tablet, and one or more lubricants in a total amount of 0.05 to 7% in weight based on the total weight of the dispersible tablet.

6. The dispersible tablet according to any one of the preceding claims wherein compound I is in the monohydrate form.

7. The dispersible tablet according to any one of the preceding claims obtainable by using the method of direct compression.

8. A method for treating pulmonary arterial hypertension, comprising dispersing the dispersible tablet of claim 1 in aqueous media to form a suspension and administering the suspension to a patient in need thereof.

9. A process for the preparation of a dispersible tablet according to any one of claims 1 to 7, characterized in that the tablet is prepared by direct compression.

10. The dispersible tablet of claim 1, wherein the pharmaceutically acceptable excipients include a flavoring agent and/or a sweetener.

11. The dispersible tablet of claim 1 which disintegrates completely in water at 15-22.degree. C. in not more than 5 minutes.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.